Metformin May Reduce Long COVID in Non-Diabetic Population
LOS ANGELES — Metformin prescribed within a week of SARS-CoV-2 infection was associated with a 53% reduction in long COVID or death over 6 months in people without diabetes or prediabetes, according to data presented on Saturday at the Infectious Disease Week (IDWeek) 2024 Annual Meeting…
Read more